iguratimod has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Abed, Y; Bloom, J; Casabar, J; Cheng, KF; Coleman, T; Forsthuber, T; He, M; Metz, C; Nalawade, S; Sherry, B | 1 |
| Aikawa, Y; Makino, S; Matsumoto, Y; Shin, T; Tanaka, K; Tanuma, N | 1 |
2 other study(ies) available for iguratimod and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
Topics: Animals; Cell Line, Tumor; Chromones; Encephalomyelitis, Autoimmune, Experimental; Glucocorticoids; Humans; Intramolecular Oxidoreductases; Lipopolysaccharides; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred BALB C; Multiple Sclerosis; Sulfonamides; Tumor Necrosis Factor-alpha | 2016 |
A new anti-rheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Benzopyrans; Encephalomyelitis, Autoimmune, Experimental; Interferon-gamma; Interleukin-1; Interleukin-6; Macrophages; Microglia; Myelin Basic Protein; Rats; Rats, Inbred Lew; Spinal Cord; Sulfonamides; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1998 |